Buy KLOW Peptide Blend 80 mg in Australia
KLOW peptide blend 80 mg is supplied in Australia by Australian Research Peptides to laboratories and researchers at A$189.99, but out of stock at present. KLOW is a four-peptide blend, often described as GLOW plus KPV, in one freeze-dried vial. GHK-Cu, BPC-157, TB-500 and KPV are dried together into a single cake at a nominal ~50/10/10/10 mg split, not an assayed one. Its research context covers cell migration and inflammatory signalling, with GHK-Cu making up most of the mass. Post reaches every Australian state and territory. In vitro research purposes only.
Copper Peptide Research · Lyophilised Powder · Independently lab-tested · SKU 92659
$189.99
KLOW 80 mg is sold out for now. Leave your email and ARP will send you one email the day it is back. Nothing else.
Presentation
80 mg per vial
Grade
Research Grade
Form
Lyophilised Powder
Category
Copper Peptide Research
This strength is not in stock — stocked lines dispatch same business day before 12pm Sydney time, Mon–Fri
Tracked shipping Australia-wide · typically 1–2 business days to most areas by Express Post · free post over $199, free Express over $299
For in vitro research purposes only. Not for human consumption. Not for animal consumption. This product is not a drug, food, cosmetic, or dietary supplement. No medical, therapeutic, or usage information is provided.
KLOW 80 mg
$189.99
In stock in the same research category: GHK-Cu 100 mg
KLOW is out of stock at Australian Research Peptides. GHK-Cu is in the same research category and is in stock now.
View GHK-Cu 100 mgBrowse all Copper Peptide Research
About KLOW
All four peptides in a KLOW vial come from preclinical research, and each has its own separate body of studies. GHK-Cu is studied in cell culture in relation to extracellular-matrix proteins. BPC-157 and TB-500 are studied in angiogenesis (blood-vessel formation) and cell migration assays. KPV is studied in cultured human cell lines, looking at inflammatory signalling. No published study tests the four together, so each research field named here belongs to one component, not to the mixture. Putting them in one vial is a packaging choice, and nothing here suggests four peptides sharing a vial behave differently from four kept apart.
KLOW is a name rather than a single compound, and this category lists it as a single-vial blend. The letters cover the three peptides in GLOW, which are GHK-Cu, BPC-157 and TB-500, plus KPV as a fourth. At the nominal split published on this page, the copper peptide makes up roughly five parts in eight of the vial. Because the name doesn't describe a fixed recipe, two products called KLOW can differ, and only the ingredient list and the total quantity tell you what each one is.
KPV is what makes KLOW different from GLOW. It is a chain of three amino acids, lysine, proline and valine, taken from the tail end of alpha-MSH. Its published research is in inflammation rather than structural repair, so a four-peptide vial covers two research fields where a three-peptide one covers one. All four peptides also have their own listings here, so the blend can be compared with its parts.
BAC water (bacteriostatic water) is also sold by Australian Research Peptides.
The peptide calculator works out the mg/mL concentration of a reconstituted vial.
What is in the vial
| Component | Amount per vial |
|---|---|
| GHK-Cu — the copper(II) complex of the GHK tripeptide, and the largest component by mass in the blend | ~50 mg |
| BPC-157 — a fifteen-amino-acid peptide, sequence GEPPPGKPADDAGLV per PubChem CID 9941957 | ~10 mg |
| TB-500 — the seven-amino-acid actin-binding fragment of thymosin beta-4, not the full 43-residue protein | ~10 mg |
| KPV — Lys-Pro-Val, the C-terminal three residues of alpha-MSH, and the peptide that distinguishes KLOW from GLOW | ~10 mg |
| Total | 80 mg per vial |
KLOW specifications, storage and shipping
- Compound: KLOW
- Also known as: GHK-Cu, BPC-157, TB-500 and KPV combination
- Class: Four-peptide blend
- Appearance: Lyophilised powder
- Quantity: 80 mg
- SKU: 92659
- Sizes & SKUs: 80 mg (92659)
- Presentation: sealed glass vial
- Form: Lyophilised Powder
- Grade: Research grade
- Testing: Independently lab-tested by Janoshik
- Identity confirmation: Mass spectrometry
- Classification: In vitro research purposes only — laboratory reference material
- Lyophilised — long term
- −20 °C to −80 °C — long-term storage
- Lyophilised — short term
- 2–8 °C — refrigerated, for a few months
- Reconstituted
- 2–8 °C — use within 8–12 weeks
KLOW is independently lab-tested by Janoshik. No laboratory report is published for this strength yet. The COA library lists every product and strength, and says which reports are available.
This strength is not in stock today. Stocked lines ordered before 12pm Sydney time on a business day are dispatched the same day with tracked shipping. Standard delivery within Australia typically takes 2–5 business days. See Shipping & Delivery for details, and follow your parcel on the Track Order page.
For in vitro research purposes only. Not for human consumption. Not for animal consumption. Not a drug, food, cosmetic, or dietary supplement. No therapeutic or medical claims are made.
Questions about KLOW
This question guide from Australian Research Peptides covers KLOW in Australia: what the listing contains, live buying and delivery questions, research context, handling, testing and comparisons. Start with the quick answers, then open the topic group that matches your search.
Quick answers
KLOW 80 mg is offered in Australia by Australian Research Peptides, for laboratories and researchers, as one 80 mg vial for A$189.99, out of stock at the moment. One sealed vial holds a single freeze-dried cake of GHK-Cu, BPC-157, TB-500 and KPV, and each of the four also has its own listing. Tracked Express Post and standard post reach every state and territory. There is no KLOW vial to send right now, but the weekday 12pm Sydney time cut-off applies again once stock is back, and parcels travel entirely within Australia, so customs never sees them.
KLOW is a four-peptide blend supplied as one freeze-dried cake in a single 80 mg vial, and it contains GHK-Cu, BPC-157, TB-500 and KPV. Those are the three peptides in GLOW, plus KPV, which is where the K at the start of the name comes from. Three of them are studied in cell-signalling and extracellular-matrix research and KPV in inflammation research, so one vial covers two fields rather than one.
Yes, KLOW is independently lab-tested before Australian Research Peptides supplies it, and having four peptides in one vial makes that job harder than testing one. Mass spectrometry has four expected masses to check instead of one. What the testing confirms is the identity of the batch that was tested, and nothing about any other batch.
One KLOW vial falls just short of free Standard tracked post, but close enough that adding a small second item usually takes the order over the threshold. Two vials clear both that threshold and the higher Express Post one in one go, which no other four-peptide order in the Australian Research Peptides range does. Free shipping is judged on the goods subtotal before any discount code, so a code can never push an order back below either threshold.
KLOW puts GHK-Cu, BPC-157, TB-500 and KPV into one 80 mg vial, so the fair comparison is against buying the four separate Australian Research Peptides listings at their prices on the day. One thing makes that comparison awkward: the smallest GHK-Cu listing is a 100 mg vial, so matching the copper-peptide share of a KLOW vial means buying about twice what the blend holds. Buying separately gives you back control, because the ratio inside KLOW is fixed at blending, while four separate vials can be varied.
KLOW has no single mechanism, because its four peptides each have their own molecular target and their own body of research behind them. GHK-Cu binds copper(II) and is studied in cell culture in relation to collagen and elastin synthesis. TB-500's seven-amino-acid section is the actin-binding region of thymosin beta-4. BPC-157 is described in the literature in relation to Akt-eNOS and VEGFR2 signalling. KPV enters cells through a peptide transporter and is studied in relation to NF-kappaB and MAP kinase signalling.
Buying, price and availability
To find out when KLOW is available again, enter your email address in the KLOW stock alert, and that address is used for that one message and nothing else. There is no newsletter, no promotions and no sharing with anyone. It is a one-off record for this single product, and it is not the same as having an account or a marketing subscription.
KLOW is supplied in Australia by Australian Research Peptides Pty Ltd, an Australian company selling direct rather than reselling an overseas listing. KLOW is independently lab-tested before release, and Australian Research Peptides' CoA library shows which products and strengths have a certificate published. Australian Research Peptides also publishes a component table naming all four peptides in the vial. Orders are paid by PayID or bank transfer and posted nationwide, and once a vial is back, an order paid before 12pm Sydney time leaves that business day.
KLOW costs A$189.99 for the 80 mg vial (out of stock) at Australian Research Peptides, the only size it comes in, so there is no second size to compare it with. The useful comparison is against another multi-peptide vial and its total milligrams, not a single-peptide listing. KLOW ships again once it is restocked.
You can get KLOW online by ordering it from Australian Research Peptides, which takes orders online only, with no phone line to call and no counter to visit. The four-peptide vial comes in a single 80 mg size, so there is only one stock level to keep an eye on. Payment is by PayID or bank transfer only, with the order reference included so the payment can be matched. Delivery is tracked to any Australian address.
No, you can't buy KLOW at Chemist Warehouse, which doesn't carry it or any product like it; the blend comes from Australian Research Peptides. It brings four research peptides together in one vial, and none of them is approved for supply in Australia. Australian Research Peptides lists it as a single 80 mg research vial.
Identity, names and exact format
There is no single amino acid count for KLOW, because four separate chains share the vial: BPC-157 has fifteen, TB-500 has seven, and GHK and KPV have three each. BPC-157's sequence is GEPPPGKPADDAGLV in PubChem. The TB-500 fragment is LKKTETQ, positions 17 to 23 of mature thymosin beta-4 (UniProt). GHK is glycine, histidine and lysine, and the copper attached to it is not itself an amino acid. KPV is lysine, proline and valine.
KPV is added to the KLOW blend to bring in inflammation research, a field the other three peptides don't cover, so the vial reaches two research areas instead of one. KPV is lysine, proline and valine, the last three amino acids of alpha-MSH. Unlike the other three components it is a bare tripeptide, with no copper centre and no long chain. In cultured human cell lines it is studied in relation to NF-kappaB and MAP kinase, two of the switches a cell uses to turn inflammation on.
An 80 mg KLOW vial is made to a four-way recipe of roughly 50 mg of GHK-Cu and roughly 10 mg each of BPC-157, TB-500 and KPV. These are nominal recipe amounts that the KLOW name carries across this category, and they add up exactly to the mass printed on the label. They are not a measurement of your vial, which is why each keeps a tilde (~). A per-component figure to two decimal places would claim a measurement nobody has taken. If the exact split matters for your work, ask before ordering.
KLOW is blue because one of its four peptides is GHK-Cu, and the copper at the centre of that complex gives both the powder and the solution a strong blue colour. So a blue KLOW vial is exactly what you should expect, not a fault. Cloudiness, particles or undissolved material are the things worth questioning.
KLOW is supplied as one vial, not four vials packed together, with all four peptides freeze-dried into a single cake inside one sealed, tamper-evident glass vial. Once combined, they can't be separated. If your work needs them apart, Australian Research Peptides sells each of the four on its own listing, and GLOW covers three of them in a single vial.
KLOW stands for the four peptides in the vial, which are the three GLOW peptides, GHK-Cu, BPC-157 and TB-500, plus KPV. No standards body defines the name, so two suppliers using it don't have to fill a vial the same way. Check the listed ingredients and the total milligrams rather than the four letters, because those tell you what a vial actually contains.
The KLOW blend is four research peptides, GHK-Cu, BPC-157, TB-500 and KPV, freeze-dried together into one 80 mg vial instead of four separate vials. One vial means one storage decision, one diluent volume and one reconstitution instead of four. The trade-off is control: the ratio is fixed when the blend is made, so no single component can be increased or left out.
Yes, KLOW peptide and KLOW 80mg are the same listing, a single 80 mg vial of four research peptides, where 80 mg is the total amount in the vial, not the strength of any one component. People often write it in the singular even though four peptides share the vial, and Australian Research Peptides keeps one listing behind every version of the name. KLOW 80 without the mg means the same product too, because the blend is sold in one size only.
Research context and evidence
No published study has tested KLOW as a blend, and that is the most useful fact to know about the research behind it. Each of the four peptides has its own separate preclinical record, and adding four records together doesn't produce a finding about the blend. TB-500's actin-binding section has been characterised in endothelial cell assays at nanomolar concentrations. GHK-Cu has been characterised in fibroblast culture and KPV in cultured human cell lines. None of that is a controlled human result, and Australian Research Peptides makes no claim beyond the vial's identity.
KLOW's GHK-Cu component has been studied in cultured fibroblasts, a type of connective-tissue cell, at picomolar concentrations, which are extremely small amounts. A 1988 FEBS Letters paper measured collagen synthesis in the dish across a range of concentrations, with the response starting between 1 and 10 pM and peaking at 1 nM. Cell numbers did not change over that range. These are concentrations in glassware, not amounts given to a living animal.
KLOW has no single shared stability figure, because it carries four peptides and only BPC-157 has a published plasma stability number, under thirty minutes, according to Mateescu's 2026 Pharmaceutics review. The thymosin fragment, the copper tripeptide and KPV have no such measurement. Nothing in the literature describes a four-way mixture at all, so any stated breakdown time would be made up rather than based on evidence.
The research areas behind KLOW are those of its four peptides: cell migration, inflammatory signalling, gut-lining and barrier work, and extracellular-matrix biology. GHK-Cu is the component with a research record in extracellular-matrix biology, while KPV pulls the blend toward inflammation and immune-regulation research. No study has looked at the four together, so each of those areas belongs to one component, not to the mixture.
There is no human safety data for KLOW, and none for any of its four peptides used as part of a blend. The published research on every component stops at cultured cells and animal models, so none of it describes what happens in a person. Two of the four are scheduled in Australia. Australian Research Peptides supplies KLOW for in vitro research only and makes no safety claim about it.
Handling, storage and measurements
An 80 mg KLOW vial rarely looks empty, because eighty milligrams is a clearly visible amount and the GHK-Cu runs a blue tint through the dried powder. What buyers do sometimes report is a cake that has broken loose and rattles around in pieces. Freeze-dried powder is brittle and doesn't travel well in one piece, but broken pieces dissolve exactly the same as an intact cake.
KLOW should be stored sealed, dry, dark and cold, below -15 °C for anything long-term, because every peptide in the vial contains lysine, which makes the whole powder draw in moisture. Let the vial reach room temperature in a desiccator (a dry container) before opening it. Only the TB-500 part contains glutamine, one of the five amino acids that make keeping a peptide in solution risky, so reconstituted material is not for keeping.
To reconstitute KLOW, you dissolve it as one powder in a single step, not four, because the four peptides were dried together into a single cake. A water-based (aqueous) diluent is the usual choice, and one volume covers all four. Run it down the inside wall of the vial rather than onto the cake, then swirl gently instead of shaking. The volume you add sets the strength of the solution. Keep the result cold and split it into single portions.
Reconstituted KLOW keeps for 8 to 12 weeks in the fridge at 2-8 °C, the working life Australian Research Peptides gives it, with the first of its four peptides to break down setting that limit for all of them. Only the TB-500 component ends in glutamine, which Bachem lists among the amino acids that shorten a peptide's life in solution; the other three have none. No stability study has been published on four peptides sharing one cake, so treat that window as a handling limit, not a measured shelf life. An 80 mg vial is a lot to get through.
No fill volume is published for the KLOW 80 mg vial, because the right volume depends on the work being done, not on the product. Whatever goes in applies to all four peptides together, never to one on its own. The four component amounts on this page describe the recipe the name is made to, not a measurement of your vial, so they won't give four reliable separate concentrations.
KLOW can look cloudy after mixing because four peptides dried into one cake dissolve more slowly than a single compound, so the in-between stage can look wrong when it isn't. The copper gives a blue tint, which should stay see-through. Bubbles from handling fade on their own. Material still floating once the liquid has warmed up and settled is undissolved powder, and a preparation like that should be thrown away.
KLOW arrives as a dry cake and is dissolved for laboratory work in a water-based (aqueous) diluent, with one volume covering all four peptides because they were dried together. That volume sets one combined concentration for the whole blend. A KLOW vial holds only dry powder, with no liquid of any kind inside.
Yes, an 80 mg KLOW vial needs more diluent than a 10 mg peptide to reach the same concentration, because volume scales with milligrams and KLOW is the second-largest vial in the catalogue. Australian Research Peptides doesn't publish a fill volume for it, and nothing else comes with the vial.
Testing and batch documents
Whether KLOW comes with a certificate of analysis is shown in Australian Research Peptides' CoA library, which is the only record of which products and strengths currently have one published. This page can't confirm it on its own, and neither the grade on a listing nor another product's report counts. KLOW is a four-peptide blend, so any certificate for it has four components to identify rather than one. No matching certificate is currently published for this product and strength.
Ordering, payment and Australian delivery
A KLOW order takes 1–2 business days to arrive by Express Post in the fastest states and up to four in the slowest, or 2–5 business days by standard tracked post. The delivery checker on the Australian Research Peptides site gives an estimate for your exact postcode rather than a capital-city average. Transit times are the carrier's, counted in business days after the parcel is lodged, and they are estimates, not guarantees.
You can pay for KLOW by PayID, a bank-run service rather than a third party, which links a phone number, email or ABN to an existing Australian bank account. The money moves directly between banks over the New Payments Platform, and you start the payment in your own banking app, so Australian Research Peptides never holds any of your payment details. Put the order reference in the description, because that is the only thing linking the transfer to your order.
Access and regulatory questions
KLOW is supplied in Australia by Australian Research Peptides as laboratory research material, not as a medicine, so no KLOW vial is approved by the TGA or registered here for human or veterinary use. Two of the four peptides in the vial are scheduled in Australia and two, GHK-Cu and KPV, are not, so one vial holds compounds in two different legal positions. Australian Research Peptides doesn't give legal advice; a question about specific work is one for a lawyer or a compliance adviser.
No, KLOW is not FDA approved or an approved medicine anywhere else, and none of its four peptides is approved on its own either. No authority has reviewed a four-peptide mixture like this for safety, quality or effectiveness. Approval applies to one defined product, made to one standard, for one stated purpose. A research blend meets none of those conditions.
Yes, KLOW is banned in sport because at least two of its four peptides are prohibited, with BPC-157 listed under S0 and TB-500 among the S2 growth factors. KPV and GHK-Cu aren't named anywhere, but that settles less than it seems, because one prohibited component in a sample is enough. Sport Integrity Australia is the Australian authority.
Importing KLOW into Australia is harder to answer than importing a single compound, because one declared item covers four peptides that don't all have the same status under Australian law. None of the four is licensed as a medicine in any country, so the personal-importation route has no overseas-approved product to rely on. Australian Research Peptides holds KLOW in Australia and posts it between two Australian addresses, which takes the border out of the picture entirely. That doesn't change what the material is, or what the person holding it is responsible for.